What Is Selank? Uses, Benefits, Safety, FDA Status, and Evidence

Medical review note: This article is for educational purposes only and does not provide medical advice. Selank is not FDA-approved for human therapeutic use in the United States. Products sold online as Selank, Selank acetate, TP-7, nasal Selank, or “research use only” Selank may carry safety, quality, legal, and regulatory risks.

Quick answer

Selank is a synthetic heptapeptide, also known as TP-7, related to the natural immunomodulatory peptide tuftsin. It has been studied mainly in Russian clinical and preclinical research for anxiety, stress response, cognition, neuropeptide metabolism, immune modulation, and gene-expression effects. Some human studies report anxiolytic effects in anxiety-spectrum disorders, including generalized anxiety disorder and neurasthenia, and one comparative study reported anxiolytic and mild nootropic effects versus phenazepam. However, the evidence base is limited, geographically concentrated, and not enough to make Selank a standard FDA-approved anxiety treatment. Selank is not FDA-approved in the U.S., and FDA says compounded drugs containing Selank acetate may pose immunogenicity risk because of potential aggregation and peptide-related impurities, while FDA lacks important safety information about Selank acetate administered to humans.

Key facts about Selank

Question	Answer
What is Selank?	A synthetic heptapeptide related to tuftsin and studied for anxiety, cognition, stress response, and immune modulation.
Other names	Selank acetate, TP-7, Thr-Lys-Pro-Arg-Pro-Gly-Pro, tuftsin analog.
Peptide class	Synthetic neuropeptide / tuftsin analog / anxiolytic research peptide / immunomodulatory peptide.
Main mechanism	Proposed modulation of neuropeptide metabolism, enkephalin-related pathways, monoamine signaling, immune cytokines, gene expression, and stress-response systems.
FDA-approved?	No. Selank is not an FDA-approved drug in the United States.
Main studied uses	Generalized anxiety disorder, neurasthenia, anxiety-spectrum disorders, stress response, cognition, immune modulation, and neuropeptide metabolism.
Human evidence level	Limited human evidence, mostly Russian clinical literature; not enough for FDA-approved anxiety or cognitive-enhancement claims.
Animal/lab evidence level	Moderate preclinical evidence for anxiolytic-like, stress-related, immune, and gene-expression effects.
Common online claims	“Anti-anxiety peptide,” “nootropic peptide,” “non-sedating anxiolytic,” “focus peptide,” “stress peptide,” “GABA support,” “mood peptide.”
Sports status	Not found here as specifically named on the WADA prohibited list; athletes should verify current WADA/Global DRO status before use.
Main safety concern	Limited U.S.-standard clinical safety evidence, FDA-identified immunogenicity and impurity concerns for compounded Selank acetate, unknown long-term safety, and risks from unapproved online products.

What is Selank?

Selank is a synthetic heptapeptide related to tuftsin. Tuftsin is a naturally occurring tetrapeptide involved in immune signaling. Selank was designed as a longer synthetic peptide based on tuftsin-related biology.

Selank is commonly described by the sequence:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

It is also called TP-7 in some literature and regulatory documents.

Selank is usually discussed as a neuropeptide or nootropic peptide because it has been studied for anxiety, stress response, mood, cognition, and immune modulation. It is commonly sold online as an intranasal peptide, though online availability does not equal approval, quality, or safety.

A PubMed-indexed clinical study on Selank in generalized anxiety disorder and neurasthenia reported changes in leu-enkephalin metabolism and anxiety-related parameters during Selank treatment.

The key distinction:

Selank has some human anxiety-focused research, but it is not an FDA-approved anxiety medication, cognitive enhancer, or psychiatric treatment in the United States.

How does Selank work?

Selank’s mechanism is not fully established. The literature discusses several possible pathways:

Neuropeptide metabolism
Enkephalin-related pathways
Anxiety and stress-response systems
Monoamine signaling
GABA-related modulation
Immune cytokine regulation
Gene-expression effects
Brain functional connectivity
Neuroinflammatory and neuroprotective pathways

A PMC study on Selank and gene expression reported that Selank administration affected expression of genes involved in neurotransmission and immune processes.

A PMC animal study reported that Selank enhanced diazepam’s anxiety-reducing effects in rats under experimentally induced anxiety conditions.

In plain English:

Selank is studied because it may affect both nervous-system and immune-system signaling involved in stress and anxiety.

But mechanism is not proof.

A proposed neuropeptide, immune, or GABA-related mechanism does not prove that Selank safely treats anxiety, replaces benzodiazepines, improves focus, cures depression, repairs the brain, or works as a reliable nootropic in humans.

What is Selank used for?

Selank is commonly discussed for anxiety, stress, focus, cognition, mood, immune modulation, and benzodiazepine alternatives. These uses differ sharply in evidence quality.

| Use | Evidence level | What is known | What is not known | |---|---|---| | Generalized anxiety disorder | Limited human evidence | Russian clinical studies report anxiolytic effects and possible neuropeptide-metabolism changes. | It is not FDA-approved for GAD, and evidence is not comparable to large modern psychiatric drug trials. | | Anxiety-spectrum disorders | Limited human evidence | A comparative study reported anxiolytic and mild nootropic effects versus phenazepam. | Independent replication and broader clinical validation are limited. | | Stress response | Preclinical / mechanistic | Animal and gene-expression research suggest stress-response effects. | Human stress-treatment benefit is not established by robust trials. | | Cognition / nootropic use | Weak to limited | Some studies discuss cognitive or nootropic-like effects. | It is not proven as a cognitive enhancer in healthy people. | | Immune modulation | Preliminary human/preclinical | Some studies report cytokine or immune-related effects. | It is not an approved immunomodulatory drug. | | Benzodiazepine alternative | Not established | Some comparisons to benzodiazepine-like anxiolytic effects exist. | It should not be treated as a proven replacement for standard anxiety care. | | Depression | Preclinical / weak | Animal models discuss depression-like behavior. | Human depression-treatment evidence is inadequate. | | Online research-use Selank | High uncertainty | Sellers market it as nasal spray, drops, or research peptide. | Quality, sterility, identity, dosing, and safety may be unknown. |

What does the research show?

Human evidence for anxiety

Selank has some human clinical literature, but the evidence base is limited.

A PubMed-indexed study evaluated Selank in generalized anxiety disorder and neurasthenia and discussed possible mechanisms involving leu-enkephalin metabolism.

A PubMed-indexed comparative study compared Selank and phenazepam in 60 patients with phobic-anxiety and somatoform disorders and reported pronounced anxiolytic and mild nootropic effects of Selank.

A PubMed-indexed study examined treatment optimization for anxiety-spectrum disorders with a combination of benzodiazepine tranquilizers and Selank.

The practical interpretation:

Selank has real human anxiety-focused research, but it is not supported by the kind of large, multi-center, FDA-standard evidence base used for approved anxiety medications.

Human evidence for immune effects

Selank has also been studied for immune and cytokine effects.

A PubMed-indexed study reported immunomodulatory effects of Selank in patients with anxiety-asthenic disorders and suggested cytokine-regulating effects.

The practical interpretation:

Selank may have immune-related biological effects, but that does not establish it as a safe or approved immune therapy.

Brain connectivity and cognition research

A PubMed-indexed functional-connectivity study evaluated effects of Selank and Semax on resting-state brain connectivity in healthy participants.

The practical interpretation:

Brain-connectivity research is interesting, but it does not prove practical cognitive enhancement, focus improvement, or nootropic benefit in everyday use.

Animal and mechanistic evidence

Preclinical evidence supports Selank’s biological activity in stress and anxiety-related models.

A PMC study reported that Selank enhanced diazepam’s effect in reducing anxiety-like behavior in rats.

A PubMed-indexed animal study examined Selank during a rat model of acute alcohol withdrawal.

The practical interpretation:

Animal studies support biological plausibility, but they do not prove clinical safety or efficacy for consumer Selank products.

FDA safety and compounding context

FDA has specifically flagged Selank acetate in the compounding-risk context.

The FDA page on bulk drug substances that may present significant safety risks states that compounded drugs containing Selank acetate may pose immunogenicity risk for certain routes of administration due to potential aggregation and peptide-related impurities. FDA also says it lacks important information regarding safety issues raised by Selank acetate administered to humans.

The practical interpretation:

Selank should not be treated as a harmless nasal nootropic. FDA has identified safety-data gaps and product-characterization concerns for compounded Selank acetate.

Evidence summary

Claim	Evidence verdict	Explanation
“Selank is a synthetic peptide related to tuftsin.”	Supported	Selank is commonly described as a tuftsin-related heptapeptide.
“Selank has anxiolytic effects.”	Limited human evidence	Some human studies report anxiolytic effects, but evidence is limited and not FDA-standard.
“Selank treats generalized anxiety disorder.”	Not established as a U.S. approved claim	It has been studied in GAD, but it is not FDA-approved for GAD.
“Selank is a nootropic.”	Weak to limited	Some cognitive/nootropic-like findings are reported, but broad cognitive-enhancement claims are not proven.
“Selank is non-addictive and risk-free.”	Unsupported	Lack of benzodiazepine-like sedation does not prove long-term safety or no risk.
“Selank replaces benzodiazepines.”	Not established	Comparative and adjunctive studies exist, but replacement claims are too strong.
“Selank is FDA-approved.”	False	Selank is not FDA-approved in the U.S.
“Selank is safe because it is a peptide.”	False	FDA has identified immunogenicity and impurity concerns for compounded Selank acetate.
“Selank is banned in sports.”	Not specifically found here	It was not found here as specifically named on WADA’s prohibited list, but athletes should verify.
“Research-use Selank is clinically proven.”	False	Research-use products are not FDA-approved consumer therapeutic products.

Is Selank FDA-approved?

No. Selank is not FDA-approved in the United States.

There is no FDA-approved Selank product for anxiety, stress, depression, cognition, ADHD, panic disorder, sleep, immune support, or nootropic use.

The FDA compounding safety-risk page states that compounded drugs containing Selank acetate may pose immunogenicity risk for certain routes of administration because of potential aggregation and peptide-related impurities. FDA also states that it lacks important safety information regarding Selank acetate administered to humans.

The key distinction:

Selank is an experimental or regionally studied neuropeptide, not an FDA-approved prescription medication in the United States.

Is Selank legal?

Selank’s legal status depends on product type, intended use, jurisdiction, and how it is sold.

The practical answer is simple:

Selank is not an FDA-approved drug in the U.S., and online availability does not mean it is legally marketed for human therapeutic use.

Some sellers market Selank as a research peptide, nootropic spray, or peptide therapy product. That does not make it safe, approved, legal, or appropriate for consumer use.

The blunt version:

Buying “research use only” Selank online is not the same as receiving an FDA-approved anxiety medication from a legitimate pharmacy.

Is Selank banned in sports?

I did not find Selank specifically named on the WADA prohibited list in the sources reviewed here.

However, athletes should be careful for three reasons:

Peptide products can be contaminated or mislabeled.
Anti-doping status can change.
Non-approved pharmacologic substances can create risk depending on jurisdiction, use, and classification.

The WADA Prohibited List should be checked directly before use.

The practical advice:

Athletes should verify Selank through Global DRO, WADA, or USADA before using it and should avoid unapproved online peptide products.

Safety and side effects

Selank should not be treated as risk-free.

Possible or theoretical concerns include:

Nasal irritation for intranasal products
Headache
Dizziness
Fatigue
Nausea
Mood changes
Immune or cytokine effects
Drug-interaction uncertainty
Unknown long-term psychiatric safety
Unknown long-term immune effects
Immunogenicity risk
Peptide aggregation risk
Peptide-related impurities
Product-quality and sterility risks from online sources
Mislabeling or incorrect concentration

The biggest safety issue is uncertainty.

FDA says important safety information is lacking for Selank acetate administered to humans, and compounded products may pose immunogenicity risk because of aggregation and peptide-related impurities.

A serious evaluation of Selank should separate controlled research from online peptide/nootropic marketing.

Selank vs similar peptides and drugs

Compound	Category	Main difference
Selank	Tuftsin-related synthetic heptapeptide	Studied for anxiety, stress response, cognition, immune modulation, and neuropeptide metabolism.
Semax	ACTH-derived synthetic peptide	Studied for cognition, neuroprotection, and stroke-related contexts; different origin and mechanism.
Afobazole	Russian anxiolytic drug	Non-benzodiazepine anxiolytic, not a peptide.
Phenazepam	Benzodiazepine	Sedating anxiolytic with dependence and safety concerns; not similar to Selank.
Benzodiazepines	Prescription anxiolytics	FDA-approved examples exist, but they carry sedation, dependence, and withdrawal risks.
SSRIs/SNRIs	Standard anxiety/depression drugs	Larger evidence base and FDA-approved uses for many anxiety disorders.
GABA supplements	Supplements	Not comparable to peptide pharmacology or prescription anxiolytics.
Dihexa	Angiotensin IV-derived experimental compound	Studied for synaptogenesis/cognition; not a tuftsin analog.

The key distinction:

Selank belongs in the neuropeptide/anxiolytic research category. It is not a GLP-1 drug, growth hormone peptide, cosmetic peptide, or FDA-approved psychiatric medication.

Why is Selank sold as “research use only”?

Some online sellers use “research use only” language to sell Selank outside normal prescription-drug channels.

That label is not a trust signal.

A serious reader should understand this distinction:

Product type	What it means
Laboratory Selank	Research peptide used in controlled experimental settings.
FDA-approved Selank	Does not currently exist in the U.S.
Compounded Selank acetate	FDA has raised immunogenicity, impurity, and safety-information concerns.
Research-use Selank	Not an FDA-approved consumer therapeutic product.
Online nasal Selank	Higher risk for identity, purity, sterility, concentration, and dosing problems.

How to evaluate Selank claims online

Claim	What to verify
“FDA-approved Selank”	False in the U.S. Selank is not FDA-approved.
“Clinically proven anxiety peptide”	Check whether evidence is from large modern clinical trials or small/regional studies.
“No side effects”	Unsupported. FDA has safety-data concerns, and long-term human safety is not established.
“Non-addictive benzodiazepine alternative”	Too strong. Selank is not an FDA-approved benzodiazepine replacement.
“Boosts focus and cognition”	Check whether evidence is human cognitive outcome data or nootropic marketing.
“Supports GABA”	Mechanistic claims do not prove clinical benefit.
“Immune support peptide”	Immune effects may exist, but it is not an approved immunotherapy.
“Research use only”	This does not mean safe, legal, approved, or appropriate for human use.
“Safe for athletes”	Verify through WADA, USADA, or Global DRO before use.
“Third-party tested”	Ask for batch-specific HPLC, LC-MS, identity, purity, sterility, endotoxin, microbial, and stability data.

Bottom line

Selank is a synthetic tuftsin-related heptapeptide studied for anxiety, stress response, cognition, neuropeptide metabolism, gene expression, and immune modulation. Some human studies report anxiolytic effects, especially in anxiety-spectrum disorders, but the evidence base is limited and not equivalent to the evidence supporting standard FDA-approved psychiatric medications.

The most defensible conclusion is:

Selank is a legitimate research peptide with interesting anxiety and neuroimmune biology, but it is not an FDA-approved anxiety treatment or proven nootropic in the U.S. FDA has flagged compounded Selank acetate for immunogenicity, impurity, and safety-information concerns, so online Selank products should be treated as high-risk rather than as harmless “calm and focus” sprays.

FAQ

What is Selank?

Selank is a synthetic heptapeptide related to tuftsin. It is studied for anxiety, stress response, cognition, neuropeptide metabolism, gene expression, and immune modulation.

What does Selank do?

Selank is proposed to affect neuropeptide metabolism, enkephalin-related pathways, stress-response systems, immune cytokines, and neurotransmission. Human studies suggest anxiolytic effects, but broad nootropic and psychiatric claims are not firmly established.

Is Selank FDA-approved?

No. Selank is not FDA-approved in the United States. FDA says compounded drugs containing Selank acetate may pose immunogenicity risk and that important safety information is lacking.

Is Selank used for anxiety?

Selank has been studied for anxiety-spectrum disorders, including generalized anxiety disorder and neurasthenia, but it is not an FDA-approved anxiety medication in the U.S.

Is Selank a nootropic?

Selank is often marketed as a nootropic peptide, and some research discusses cognitive or mild nootropic effects. However, strong human evidence for cognitive enhancement in healthy people is lacking.

Is Selank the same as Semax?

No. Selank and Semax are both synthetic neuropeptides studied in Russian research contexts, but they are different compounds. Selank is related to tuftsin, while Semax is ACTH-derived.

Is Selank the same as a benzodiazepine?

No. Selank is not a benzodiazepine. It is a peptide studied for anxiolytic-like effects, but it should not be treated as a proven replacement for benzodiazepines or other approved anxiety medications.

Is Selank safe?

Selank does not have enough U.S.-standard long-term human safety data to call it safe for consumer use. FDA has raised concerns about immunogenicity, peptide aggregation, peptide-related impurities, and lack of important safety information.

Is Selank legal?

Selank is not an FDA-approved drug in the U.S. Online sales as a research peptide do not mean it is legally marketed for human therapeutic use.

Is Selank banned in sports?

I did not find Selank specifically named on the WADA prohibited list in the sources reviewed here. Athletes should verify current status with WADA, USADA, or Global DRO before use.

Why do sellers call Selank “research use only”?

Sellers often use “research use only” language because Selank is not FDA-approved for consumer therapeutic use in the U.S. The phrase does not make the product safe, legal, approved, or clinically proven.

What is the biggest risk with Selank?

The biggest risks are using an unapproved neuroactive peptide without adequate safety data, relying on small or regional studies instead of FDA-standard evidence, and buying online products with uncertain identity, purity, sterility, concentration, and stability.

Sources

Frequently asked questions

What is Selank?

Selank is a synthetic heptapeptide related to tuftsin. It is studied for anxiety, stress response, cognition, neuropeptide metabolism, gene expression, and immune modulation.

Is Selank FDA-approved?

No. Selank is not FDA-approved in the United States. FDA says compounded drugs containing Selank acetate may pose immunogenicity risk and that important safety information is lacking.

Is Selank used for anxiety?

Selank has been studied for anxiety-spectrum disorders, including generalized anxiety disorder and neurasthenia, but it is not an FDA-approved anxiety medication in the U.S.

Is Selank a nootropic?

Is Selank the same as Semax?

No. Selank and Semax are both synthetic neuropeptides studied in Russian research contexts, but they are different compounds. Selank is related to tuftsin, while Semax is ACTH-derived.

Is Selank safe?

Is Selank banned in sports?

No official WADA source was found here specifically naming Selank as prohibited. Athletes should verify current status with WADA, USADA, or Global DRO before use.

Sources

[1]
PubMed: Efficacy and possible mechanisms of action of Selank in generalized anxiety disorders and neurasthenia
Clinical
[2]
PubMed: Comparison of the anxiolytic effect and tolerability of Selank and phenazepam
Clinical
[3]
PubMed: Optimization of the treatment of anxiety disorders with Selank
Clinical
[4]
PubMed: Immunomodulatory effects of Selank in patients with anxiety-asthenic disorders
Clinical
[5]
PMC: Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
Preclinical
[6]
PMC: Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Rats
Preclinical
[7]
PubMed: Functional connectomic approach to studying Selank and Semax
Human Biomarker
[8]
PubMed: Efficacy of peptide anxiolytic Selank during modeling of alcohol withdrawal in rats
Preclinical
[9]
FDA: Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks
Regulatory
[10]
FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A
Regulatory
[11]
WADA: Prohibited List
Anti Doping
[12]
WADA: 2026 Prohibited List
Anti Doping

Last updated May 9, 2026